Supporting Digital Skills Development: Beeline Kazakhstan Adds New Secondary School to Award-Winning CSR Programme
September 02, 2024 04:00 ET
|
VEON Ltd.
Amsterdam and Almaty, 2 September 2024 – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator that provides connectivity and online services (“VEON” or the “Company”),...
Golar LNG Limited – Fixed income investor meetings
September 02, 2024 01:20 ET
|
Golar LNG
Golar LNG Limited (“Golar”) has mandated DNB Markets and Pareto Securities as Global Coordinators and Joint Bookrunners, and Clarksons Securities and Fearnley Securities as Joint Bookrunners, to...
Belite Bio Mengumumkan Pelantikan Hendrik P. N. Scholl, MD, MA, sebagai Ketua Pegawai Perubatan
September 01, 2024 20:00 ET
|
Belite Bio, Inc
Dr. Scholl adalah pemimpin yang diiktiraf di peringkat global dalam bidang oftalmologi dan penyelidik utama penyelaras bagi kajian sejarah semula jadi terbesar bagi penyakit Stargardt. SAN DIEGO,,...
Belite Bio, 최고 의학 책임자로 Hendrik P. N. Scholl 박사 선임 발표
September 01, 2024 19:00 ET
|
Belite Bio, Inc
안과 분야에서 세계적으로 인정받는 권위자인 Scholl 박사는 스타가르트 질환 관련 사상 최대 규모의 자연사 연구 공동 책임 연구자로도 활동 중 샌디에고, Sept. 02, 2024 (GLOBE NEWSWIRE) -- 임상 단계 바이오 의약품 개발 기업인 벨라이트 바이오(Belite Bio, Inc)(나스닥: BLTE)(이하 '벨라이트 바이오'...
iRhythm Technologies Announces Results of GUARD-AF Trial
September 01, 2024 13:33 ET
|
iRhythm
GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
September 01, 2024 08:00 ET
|
Belite Bio, Inc
Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural history study of Stargardt disease SAN DIEGO, Sept. ...
Cytokinetics Presents New Data Related to the Safety and Long-Term Use of Aficamten at the European Society of Cardiology Congress 2024
September 01, 2024 04:27 ET
|
Cytokinetics, Incorporated
Data from Integrated Safety Analysis Across Three Clinical TrialsReinforces Robust Safety Profile of Aficamten Analysis from FOREST-HCM Demonstrates Successful Withdrawal of Standard of Care...
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the European Society of Cardiology Congress 2024
September 01, 2024 03:51 ET
|
Cytokinetics, Incorporated
Additional Data from SEQUOIA-HCM Demonstrate Favorable Cardiac Remodelingby Cardiac MRI, Improvements in Cardiac Structure and Function by Echocardiography,Symptom Relief and Improvement in Biomarkers...
Li Auto Inc. August 2024 Delivery Update
August 31, 2024 22:01 ET
|
Li Auto Inc.
BEIJING, China, Sept. 01, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it...
VivoPower International PLC Reports Preliminary Estimated Unaudited Financial Results for the Fiscal Year Ended June 30, 2024
August 30, 2024 17:05 ET
|
VivoPower International PLC
Annual consolidated revenue of $11.8 million down 22% year-on-year (“y-o-y”) reflecting a strategic focus towards the Electric Vehicle and Sustainable Energy Solutions business units and...